SCHEMBL19862150

SCHEMBL19862150

C1=Cc2ccc(-c3nc(-c4ccccc4)cc(-c4ccc(-c5cccnc5)nc4)n3)cc2C2(c3ccccc31)c1ccccc1-c1cc3c(cc12)oc1ccccc13

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
HDAC6 Q9UBN7 2/20 0.34
DHODH Q02127 1/20 0.33
KDM4E B2RXH2 3/20 0.32
NPC1 O15118 2/20 0.32
MAPT P10636 2/20 0.32
RAB9A P51151 2/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32
PDK2 Q15119 2/20 0.32
CYP19A1 P11511 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
GLA P06280 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19862143 0.98 CYP3A4 (0.34) GAACYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL19862193 0.98 CYP1A2 (0.34) GAACYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL19862180 0.98 GAA (0.35) GAACYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL19862198 0.96 CYP3A4 (0.34) GAACYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL19862166 0.96 GAA (0.36) GAACYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL19862200 0.95 CYP1A2 (0.34) GAACYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL19862161 0.94 CYP1A2 (0.36) GAACYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL19862163 0.94 DHODH (0.37) GAACYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL19862208 0.94 GAA (0.37) GAACYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL19862190 0.92 DHODH (0.36) GAACYP1A2CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10454039-B2 Compound and organic electronic device using the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2019-10-22 US disclosed
US-20180047918-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2018-02-15 US disclosed
US-20180047918-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180047918-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME ORC3, AOX1, RCOR3 GAA 3918/4885CYP1A2 298/4885CYP3A4 216/4885
US-10454039-B2 Compound and organic electronic device using the same ORC3, AOX1, RCOR3 GAA 3918/4885CYP1A2 298/4885CYP3A4 216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.